Honokiol: A non-adipogenic PPARγ agonist from nature

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 10, 2013, Pages 4813-4819

  Atanasov, Atanas G ^a   Wang, Jian N ^b   Gu, Shi P ^b   Bu, Jing ^b   Kramer, Matthias P ^a   Baumgartner, Lisa ^c   Fakhrudin, Nanang ^a,d   Ladurner, Angela ^a   Malainer, Clemens ^a   Vuorinen, Anna ^c   Noha, Stefan M ^c   Schwaiger, Stefan ^c   Rollinger, Judith M ^c   Schuster, Daniela ^c   Stuppner, Hermann ^c   Dirsch, Verena M ^a   Heiss, Elke H ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Metabolic disease; Natural product; Peroxisome proliferator activated receptor

Indexed keywords

HONOKIOL; LUCIFERASE; NATURAL PRODUCT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BARK; CELL DIFFERENTIATION; CHINESE MEDICINE; COMPUTER MODEL; COMPUTER PREDICTION; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG STRUCTURE; EMBRYO; ENZYME ASSAY; FEMALE; FIBROBLAST; GLUCOSE TRANSPORT; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN PURIFICATION; TRADITIONAL MEDICINE; VALIDATION PROCESS; WEIGHT REDUCTION;

3-ISOBUTYL-1-METHYLXANTHINE; AMERICAN TYPE CULTURE COLLECTION; AMP-ACTIVATED KINASE; AMPK; ANALYSIS OF VARIANCE; ANOVA; ATCC; BADGE; BISPHENOL A DIGLYCIDYL ETHER; BMP; BONE MORPHOGENIC PROTEIN 4; BOVINE SERUM ALBUMIN; BSA; CMCNA; DIMETHYL SULFOXIDE; DMEM; DMSO; DULBECCO'S MODIFIED EAGLE'S MEDIUM; EC(50); EFFECTIVE CONCENTRATION 50%; EGFP; ENHANCED GREEN FLUORESCENT PROTEIN; FCS; FETAL CALF SERUM; GLUTATHIONE-S-TRANSFERASE; GST; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HPLC; IBMX; LBD; LIGAND-BINDING DOMAIN; MAMMALIAN TARGET OF RAPAMYCIN; MEF; METABOLIC DISEASE; MOUSE EMBRYONIC FIBROBLASTS; MTOR; NADPH-DEPENDENT OXIDASE; NATURAL PRODUCT; NBS; NEWBORN BOVINE SERUM; NF-ΚB; NMR; NOX; NUCLEAR FACTOR ΚB; NUCLEAR MAGNETIC RESONANCE; PBS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; PHOSPHATE BUFFERED SALINE; PPARΓ; RETINOIC X RECEPTOR; RXR; SEM; SODIUM CARBOXYMETHYL CELLULOSE; SPECIFIC PATHOGEN FREE; SPF; SREBP; STANDARD ERROR OF THE MEAN; STEROL REGULATORY ELEMENT BINDING PROTEIN; TCM; THIN LAYER CHROMATOGRAPHY; TIME-RESOLVED FLUORESCENCE RESONANCE ENERGY TRANSFER; TLC; TR-FRET; TRADITIONAL CHINESE MEDICINE;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; BIOLOGICAL AGENTS; BIPHENYL COMPOUNDS; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; HEK293 CELLS; HUMANS; LIGNANS; MICE; MOLECULAR DOCKING SIMULATION; PPAR GAMMA;

EID: 84884684046     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.06.021     Document Type: Article

References (35)

1. F. Lalloyer, and B. Staels Fibrates, glitazones, and peroxisome proliferator-activated receptors Arterioscler. Thromb. Vasc. Biol. 30 2010 894 899
2. B. Staels, and J.C. Fruchart Therapeutic roles of peroxisome proliferator-activated receptor agonists Diabetes 54 2005 2460 2470 (Pubitemid 41134276)
3. D. Patsouris, M. Muller, and S. Kersten Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance Curr. Opin. Investig. Drugs 5 2004 1045 1050
4. B. Desvergne, L. Michalik, and W. Wahli Transcriptional regulation of metabolism Physiol. Rev. 86 2006 465 514
5. R.M. Evans, G.D. Barish, and Y.X. Wang PPARs and the complex journey to obesity Nat. Med. 10 2004 355 361 (Pubitemid 38508511)
6. M.K. Hansen, and T.M. Connolly Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis Curr. Opin. Investig. Drugs 9 2008 247 255 (Pubitemid 351323377)
7. K. Schoonjans, G. Martin, B. Staels, and J. Auwerx Peroxisome proliferator-activated receptors, orphans with ligands and functions Curr. Opin. Lipidol. 8 1997 159 166 (Pubitemid 27290462)
8. O. Bardot, T.C. Aldridge, N. Latruffe, and S. Green PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene Biochem. Biophys. Res. Commun. 192 1993 37 45 (Pubitemid 23205265)
9. K. Ge, M. Guermah, C.X. Yuan, M. Ito, A.E. Wallberg, B.M. Spiegelman, and R.G. Roeder Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis Nature 417 2002 563 567 (Pubitemid 34595925)
10. T.P. Yao, G. Ku, N. Zhou, R. Scully, and D.M. Livingston The nuclear hormone receptor coactivator SRC-1 is a specific target of p300 Proc. Natl. Acad. Sci. U. S. A. 93 1996 10626 10631 (Pubitemid 26333038)
11. M. Ricote, and C.K. Glass PPARs and molecular mechanisms of transrepression Biochim. Biophys. Acta 1771 2007 926 935 (Pubitemid 47198544)
12. B.D. Abbott Review of the expression of peroxisome proliferator-activated receptors alpha (PPAR alpha), beta (PPAR beta), and gamma (PPAR gamma) in rodent and human development Reprod. Toxicol. 27 2009 246 257
13. L. Michalik, J. Auwerx, J.P. Berger, V.K. Chatterjee, C.K. Glass, F.J. Gonzalez, P.A. Grimaldi, T. Kadowaki, M.A. Lazar, S. O'Rahilly, C.N. Palmer, J. Plutzky, J.K. Reddy, B.M. Spiegelman, B. Staels, and W. Wahli International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors Pharmacol. Rev. 58 2006 726 741 (Pubitemid 44833742)
14. R.K. Semple, V.K. Chatterjee, and S. O'Rahilly PPAR gamma and human metabolic disease J. Clin. Invest. 116 2006 581 589 (Pubitemid 43326862)
15. K. Bhalla, B.J. Hwang, J.H. Choi, R. Dewi, L. Ou, J. McLenithan, W. Twadell, E. Pozharskiy, J. Stock, and G. Girnun N-Acetyl Farnesyl cysteine is a novel class of PPAR{gamma} ligand with partial and full agonist activity in vitro and in vivo J. Biol. Chem. 286 2011 41626 41635
16. R. Agrawal, P. Jain, and S.N. Dikshit Balaglitazone: a second generation peroxisome proliferator-activated receptor (PPAR) gamma (gamma) agonist Mini-Rev. Med. Chem. 12 2012 87 97
17. N. Fakhrudin, A. Ladurner, A.G. Atanasov, E.H. Heiss, L. Baumgartner, P. Markt, D. Schuster, E.P. Ellmerer, G. Wolber, J.M. Rollinger, H. Stuppner, and V.M. Dirsch Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gamma Mol. Pharmacol. 77 2010 559 566
18. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, and R.M. Evans Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 358 1992 771 774
19. L. Peyrin-Biroulet, J. Beisner, G. Wang, S. Nuding, S.T. Oommen, D. Kelly, E. Parmentier-Decrucq, R. Dessein, E. Merour, P. Chavatte, T. Grandjean, A. Bressenot, P. Desreumaux, J.F. Colombel, B. Desvergne, E.F. Stange, J. Wehkamp, and M. Chamaillard Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon Proc. Natl. Acad. Sci. U. S. A. 107 2010 8772 8777
20. Y. Shoji, N. Takashi, K. Akihide, N. Toshihiro, and N. Itsuo Isolation and characterization of phenolic compounds from magnoliae cortex produced in China Chem. Pharm. Bull. 39 1991 2024 2036
21. S. Shin, N. Wakabayashi, V. Misra, S. Biswal, G.H. Lee, E.S. Agoston, M. Yamamoto, and T.W. Kensler NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis Mol. Cell. Biol. 27 2007 7188 7197 (Pubitemid 47549754)
22. H. Iwatsuka, A. Shino, and Z. Suzuoki General survey of diabetic features of yellow KK mice Endocrinol. Jpn. 17 1970 23 35
23. S.S. Braithwaite, B. Palazuk, J.R. Colca, C.W. Edwards III, and C. Hofmann Reduced expression of hexokinase II in insulin-resistant diabetes Diabetes 44 1995 43 48
24. T. Itoh, L. Fairall, K. Amin, Y. Inaba, A. Szanto, B.L. Balint, L. Nagy, K. Yamamoto, and J.W. Schwabe Structural basis for the activation of PPARgamma by oxidized fatty acids Nat. Struct. Mol. Biol. 15 2008 924 931
25. Y. Cheng, and W.H. Prusoff Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22 1973 3099 3108
26. P. Markt, D. Schuster, J. Kirchmair, C. Laggner, and T. Langer Pharmacophore modeling and parallel screening for PPAR ligands J. Comput. Aided Mol. Des. 21 2007 575 590 (Pubitemid 350238548)
27. E.D. Rosen, and O.A. MacDougald Adipocyte differentiation from the inside out Nat. Rev. Mol. Cell Biol. 7 2006 885 896 (Pubitemid 44871415)
28. G. Banos, I. Perez-Torres, and M. El Hafidi Medicinal agents in the metabolic syndrome Cardiovasc. Hematol. Agents Med. Chem. 6 2008 237 252
29. H. Zhang, X. Xu, L. Chen, J. Chen, L. Hu, H. Jiang, and X. Shen Molecular determinants of magnolol targeting both RXRalpha and PPARgamma PLoS One 6 2011 e28253
30. H. Kotani, H. Tanabe, H. Mizukami, M. Makishima, and M. Inoue Identification of a naturally occurring rexinoid, honokiol, that activates the retinoid X receptor J. Nat. Prod. 73 2010 1332 1336
31. S.S. Choi, B.Y. Cha, K. Iida, M. Sato, Y.S. Lee, T. Teruya, T. Yonezawa, K. Nagai, and J.T. Woo Honokiol enhances adipocyte differentiation by potentiating insulin signaling in 3T3-L1 preadipocytes J. Nat. Med. 65 2011 424 430
32. P. Misra, R. Chakrabarti, R.K. Vikramadithyan, G. Bolusu, S. Juluri, J. Hiriyan, C. Gershome, A. Rajjak, P. Kashireddy, S. Yu, S. Surapureddi, C. Qi, Y.J. Zhu, M.S. Rao, J.K. Reddy, and R. Ramanujam PAT5A: a partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic J. Pharmacol. Exp. Ther. 306 2003 763 771 (Pubitemid 36886178)
33. W. Liu, F. Lau, K. Liu, H.B. Wood, G. Zhou, Y. Chen, Y. Li, T.E. Akiyama, G. Castriota, M. Einstein, C. Wang, M.E. McCann, T.W. Doebber, M. Wu, C.H. Chang, L. McNamara, B. McKeever, R.T. Mosley, J.P. Berger, and P.T. Meinke Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulators J. Med. Chem. 54 2011 8541 8554
34. F.M. Gregoire, F. Zhang, H.J. Clarke, T.A. Gustafson, D.D. Sears, S. Favelyukis, J. Lenhard, D. Rentzeperis, L.E. Clemens, Y. Mu, and B.E. Lavan MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema Mol. Endocrinol. 23 2009 975 988
35. S. Diano, Z.W. Liu, J.K. Jeong, M.O. Dietrich, H.B. Ruan, E. Kim, S. Suyama, K. Kelly, E. Gyengesi, J.L. Arbiser, D.D. Belsham, D.A. Sarruf, M.W. Schwartz, A.M. Bennett, M. Shanabrough, C.V. Mobbs, X. Yang, X.B. Gao, and T.L. Horvath Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity Nat. Med. 17 2011 1121 1127